Clinical trial
Post-transplant Cyclophosphamide for HLA-haploidentical Transplantation in Wiskott-Aldrich Syndrome
NCT03198195 is registered in ClinicalTrials.gov with Capital Research Institute of Pediatrics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-transplant Cyclophosphamide for HLA-haploidentical Transplantation in Wiskott-Aldrich Syndrome
- Lead sponsor
- Capital Research Institute of Pediatrics
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 10, 2015
- Completion date
- July 10, 2020
- Enrollment
- 5 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.